These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27449854)

  • 21. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
    Nakamura T
    Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy.
    Kira J; Fujihara K; Itoyama Y; Goto I; Hasuo K
    J Neurol Sci; 1991 Nov; 106(1):41-9. PubMed ID: 1779238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
    Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
    Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis.
    Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC
    J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T; Ando H; Araya N; Yagishita N
    Nihon Rinsho; 2012 Apr; 70(4):705-13. PubMed ID: 22568157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I
    J Neurol Sci; 1996 Oct; 142(1-2):65-9. PubMed ID: 8902722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
    Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
    AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.
    Sarkis S; Belrose G; Peloponese JM; Olindo S; Césaire R; Mesnard JM; Gross A
    J Clin Virol; 2013 Sep; 58(1):295-8. PubMed ID: 23756056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Hara H; Morita M; Iwaki T; Hatae T; Itoyama Y; Kitamoto T; Akizuki S; Goto I; Watanabe T
    J Exp Med; 1994 Sep; 180(3):831-9. PubMed ID: 8064235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis: a semiquantitative MRI study.
    Godoy AJ; Kira J; Hasuo K; Goto I
    J Neurol Sci; 1995 Nov; 133(1-2):102-11. PubMed ID: 8583211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of immune disorder in tropical spastic paraparesis.
    Smikle MF; Barton EN; Morgan OC; Luseko J; Bailey VE; Williams EM
    Hum Antibodies; 1999; 9(2):133-7. PubMed ID: 10405834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.